CardiologyNowNews.org CardiologyNowNews.org
Font ResizerAa
  • Home
    • About
      • Message from the Editor-in-Chief
      • Mission Statement
      • Editorial Board
  • News
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Educational Resources
    • WikiDoc
    • BAIM Grand Rounds
    • Clinical Trial Results
  • ACC
    • ACC 2017
    • ACC 2018
    • ACC 2019
    • ACC 2020
    • ACC 2021
    • ACC 2022
    • ACC 2023
    • ACC 2024
    • ACC 2025
    • ACC 2026
  • AHA
    • AHA 2017
    • AHA 2019
    • AHA 2021
    • AHA 2022
    • AHA 2023
    • AHA 2024
    • AHA 2025
  • ESC
    • ESC 2017
    • ESC 2018
    • ESC 2019
    • ESC 2021
    • ESC 2022
    • ESC 2023
    • ESC 2024
    • ESC 2025
  • SCAI
    • SCAI 2017
    • SCAI 2018
  • Videos
CardiologyNowNews.org CardiologyNowNews.org
Font ResizerAa
Search
  • Home
    • About
  • News
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Educational Resources
    • WikiDoc
    • BAIM Grand Rounds
    • Clinical Trial Results
  • ACC
    • ACC 2017
    • ACC 2018
    • ACC 2019
    • ACC 2020
    • ACC 2021
    • ACC 2022
    • ACC 2023
    • ACC 2024
    • ACC 2025
    • ACC 2026
  • AHA
    • AHA 2017
    • AHA 2019
    • AHA 2021
    • AHA 2022
    • AHA 2023
    • AHA 2024
    • AHA 2025
  • ESC
    • ESC 2017
    • ESC 2018
    • ESC 2019
    • ESC 2021
    • ESC 2022
    • ESC 2023
    • ESC 2024
    • ESC 2025
  • SCAI
    • SCAI 2017
    • SCAI 2018
  • Videos
Follow US
ACC 2026News

Community-Engaged Barbershop-Based Hypertension Prevention in Black Men: Insights from the CLIP Trial

Oludamilola Aladesanmi MD
Share
3 Min Read

Key Points 

  • A barbershop-based, community health worker (CHW)-led intervention successfully engaged Black men at high risk for hypertension (HTN). 
  • A self-directed implementation strategy was as effective as a facilitated approach in preventing blood pressure rise. 
  • Both strategies blunted the expected age-related increase in systolic blood pressure over 12-18 months. 
  • The intervention reduced progression to stage 2 HTN, supporting community-based prevention models. 

Black men in the United States experience disproportionately high rates of hypertension (HTN) and related mortality, driven by structural barriers, reduced healthcare engagement, and adverse social determinants of health. Traditional clinic-based prevention strategies often fail to reach this population. Barbershops – trusted, culturally relevant community spaces – have previously demonstrated success in hypertension treatment, but their role in prevention has remained unclear. The Community-to-Clinic Linkage Implementation Program (CLIP) was developed to address this gap through CHW-led screening, counseling, and care linkage. 

CLIP (NCT05447962) was a cluster randomized controlled trial conducted in 22 barbershops in Staten Island, NY, enrolling 430 Black men with elevated blood pressure or untreated stage 1 hypertension. Barbershops were randomized to either a barbershop facilitation (BF) strategy, featuring structured support for implementation, or a self-directed (SD) approach without facilitation. All participants received BP screening, CHW-led lifestyle counseling, social needs assessment, and referral to primary care. The primary outcome was change in systolic blood pressure (SBP) at 12 months, with secondary outcomes including incident HTN, care linkage, and sustainability at 18 months. The trial design was published in American Journal of Hypertension in November 2025.

Retention was high (90% at 12 months; 95% at 18 months). At 12 months, SBP remained stable in the BF arm and decreased modestly (about 1 mm Hg) in the SD arm. The adjusted between-group difference slightly favored the SD strategy (about 1.6 mm Hg; p=0.03), though absolute changes were small. Importantly, both strategies mitigated the expected age-related increase in SBP. Progression to stage 2 HTN was lower in the BF arm at 12 months (2.9% vs. 6.9%; p=0.03), though this difference attenuated by 18 months. Diastolic BP (DBP) changes were minimal and similar between groups. 

CLIP demonstrates that community-engaged, barbershop-based interventions can be effectively implemented to prevent HTN in Black men. Notably, the lack of superiority of the facilitated approach suggests that scalable, lower-resource self-directed strategies may achieve similar outcomes. The intervention’s success likely reflects its integration of culturally trusted settings, CHW engagement, and attention to social determinants of health. Limitations include single-city implementation and difficulty isolating the most effective components of the multi-level intervention. While BP reductions were modest, preventing upward BP trajectories and delaying progression to stage 2 HTN may yield meaningful long-term cardiovascular benefits.  

As noted by principal investigator Dr. Joseph Ravenell, the study highlights that “community-engaged implementation strategies can have major implications for the prevention of hypertension in Black men,” underscoring the importance of meeting patients where they are. 

TAGGED:ACC 2026ConferenceFeaturedNews
Share This Article
Copy Link Print
CardiologyNowNews.org CardiologyNowNews.org
Copyright - CardiologyNowNews
  • Contact Us
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?